Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Hyperlipidemia Clinical Trials

100 recruiting trials for Hyperlipidemia. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
100
Total Trials
100
Recruiting Now
6
Phase 3 Trials
10
Sponsors

Recruiting Trials

RECRUITINGNCT07180368

Assessment and Management of Multiple Drug Use in Elderly Chronic Disease Patients

The purpose of this observational study is to understand the impact of polypharmacy on the prognosis of elderly patients with chronic diseases. The main research question it aims...

Sponsor: Xijing HospitalEnrolling: 20001 location
RECRUITINGNCT06694012

Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2

The aim of this study is to investigate the relationship between body fat distribution measured by CT scan and related risk factors with the risk of incident metabolic and...

Sponsor: Osaka Metropolitan UniversityEnrolling: 20001 location
RECRUITINGNCT06192251

Complete Lifestyle Medicine Intervention Program

This project will use a mixed design and will be conducted at the West Parry Sound Health Centre. Based on similar studies there is an expected 10% drop-out rate so 20...

Sponsor: Northern Ontario School of MedicineEnrolling: 81 location
RECRUITINGNCT06747000

Lipoprotein Interactions and Platelet Function in Healthy Individuals and Those With Lipid Disorders

This study looks at how lipoproteins, which are particles in the blood that transport cholesterol, influence heart and blood vessel health. Beyond just their levels, the way these...

Sponsor: The Miriam HospitalEnrolling: 802 locations
RECRUITINGNCT04529967

Child-Parent Familial Hypercholesterolemia Screening

Child-parent screening for familial hypercholesterolemia has been proposed to identify children and their parent who are carrier of mutations and with high risk for inherited...

Sponsor: Children's Hospital of Fudan UniversityEnrolling: 150006 locations
RECRUITINGNCT07200674

Interest of High-speed Centrifugation for Measuring Anti-Xa Activity on Lipemic Plasma

Some hemostasis techniques require spectrophotometric measurements. These are then subject to interference from the sample's lipemia (postprandial, hypertriglyceridemia, etc.),...

Sponsor: University Hospital, Strasbourg, FranceEnrolling: 1501 location
RECRUITINGNCT03989167

Clinical Decision Support for Familial Hypercholesterolemia

A cluster randomized study in the primary care setting to evaluate a computer-based clinical decision support system to aid in the identification and management of patients with...

Sponsor: University Hospital, LinkoepingEnrolling: 4600001 location
RECRUITINGNCT04209244

Effect of Fish Oil on Hyperlipidemia and Toxicities in Children and Young Adults With Acute Lymphoblastic Leukemia

Acute lymphoblastic leukemia (ALL) is the most common malignant disease among children. Treatment results have improved over time due to intensive risk-adapted therapy and the...

Sponsor: Rigshospitalet, DenmarkEnrolling: 1004 locations
RECRUITINGNCT06858982

PMMHRI-Pitavastatin Registry

The PMMHRI-Pitavastatin Registry is a non-interventional, single-center registry conducted at the Polish Mother's Memorial Hospital Research Institute (PMMHRI). Established in...

Sponsor: Polish Mother Memorial Hospital Research InstituteEnrolling: 5001 location
RECRUITINGNCT05457582

PCSK 9 Inhibitor Added to High-Intensity Statin Therapy to Prevent Cardiovascular Events in Patients With ACS After PCI

The primary objective was to evaluate the effect of PCSK 9 Inhibitor (initiated within 4 h from PCI for the culprit lesion) with high-intensity statin treatment, compared to...

Sponsor: Nanjing First Hospital, Nanjing Medical UniversityEnrolling: 12121 location
RECRUITINGNCT07351175

Investigating The Potential Of A Hay-Aged Cheese To Reduce Cholesterol As Mediated By Changes In The Gut Microbiome

The goal of this intervention trial is to investigate the potential of an artisan cheese aged in hay to induce changes in the gut microbiota in a manner which mediates a reduction...

Sponsor: Anisha WijeyesekeraEnrolling: 401 location
RECRUITINGEarly Phase 1NCT06125847

NGGT006 Gene Therapy for Homozygous Familial Hypercholesterolemia

This is an early phase 1, open-label, single-center, dose-escalation, pilot trial to evaluate the safety and efficacy of an intravenous infusion of NGGT006 in homozygous familial...

Sponsor: First Affiliated Hospital Xi'an Jiaotong UniversityEnrolling: 121 location
RECRUITINGNCT05325034

Guideline Oriented Approach To Lipid Lowering In Asia-Pacific

Multinational, patient-level randomised, multi-phase standard-of-care control arm, parallel group, implementation study. Patients will be recruited during hospitalisation and be...

Sponsor: Stephen NichollsEnrolling: 200020 locations
RECRUITINGNCT06568601

Pharmacogenomic Informed Statin Prescribing

Statins are the most cost-effective medications to lower cholesterol and cardiovascular disease (CVD) risk. However, many patients at high-risk for CVD do not accept or adhere to...

Sponsor: VA Office of Research and DevelopmentEnrolling: 4102 locations
RECRUITINGNCT06951386

The Impact of Daily Intake of Short-chain Fatty Acids on Cardiometabolic Risk Factors in Individuals at Risk for...

During this study, the effect of short-chain fatty acids on blood lipaedemia, glycemia, anthropometrics, blood pressure and energy expenditure will be investigated.

Sponsor: KU LeuvenEnrolling: 501 location
RECRUITINGPhase 1NCT06451770

Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia

VT-20101 is an Open-label, Phase 1b, Single-ascending dose study that will evaluate the safety of VERVE-201 administered to patients with Refractory Hyperlipidemia. VERVE-201...

Sponsor: Verve Therapeutics, Inc.Enrolling: 3610 locations
RECRUITINGNCT06374277

Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence

Socioeconomically disadvantaged populations with multiple chronic conditions have high rates of nonadherence to essential chronic disease medications after hospital discharge....

Sponsor: University of TennesseeEnrolling: 3882 locations
RECRUITINGEarly Phase 1NCT06047496

Time Restricted Eating in Sleep Apnea

Obstructive sleep apnea (OSA) is a highly prevalent disorder that is associated with both cardiovascular and metabolic dysfunction, such as hypertension, increased blood glucose...

Sponsor: University of California, San DiegoEnrolling: 801 location
RECRUITINGEarly Phase 1NCT07176923

CS-121 APOC3 Base Editing in FCS

This is an open-label, single-arm, dose-escalation Phase I clinical trial to evaluate the safety, tolerability, pharmacodynamics (PD), and pharmacokinetics (PK) of CS-121, an in...

Sponsor: CorrectSequence Therapeutics Co., LtdEnrolling: 151 location
RECRUITINGNCT05015348

Effects of Omega-3 PUFA on Lipids, Inflammatory Factors and Body Composition in Patients with Hyperlipidemia

Patients with hyperlipidemia will be allocated into intervention or control group randomly. Participants of intervention group will be provided with Omega-3 PUFA, while...

Sponsor: Peking Union Medical College HospitalEnrolling: 1201 location
RECRUITINGNCT06422741

Effect of a Grape Seed Proanthocyanidin Extract (GSPE) on LDL Cholesterol Levels in Rotating Night Shift Workers

The physiological processes of the body present daily oscillations called circadian rhythm. The circadian rhythm is essential for maintaining the vital functions of organisms,...

Sponsor: Fundació EurecatEnrolling: 222 locations
RECRUITINGPhase 2NCT05816343

Long Term Efficacy and Safety of Orlistat for Type 1 Hyperlipoproteinemia

Type I hyperlipoproteinemia (T1HLP, also known as familial chylomicronemia syndrome or FCS) is a rare diseasewhere the blood triglycerides (fats) are very high. It is caused by...

Sponsor: University of Texas Southwestern Medical CenterEnrolling: 281 location
RECRUITINGNCT06614049

AdLip: Human Coach-supported Digital/AI Personal Health Assistant to Improve Adherence to Lipid-Lowering Medication

Investigators hypothesize that the use of a human coach-supported digital/AI personal health assistant (app) will improve adherence to cholesterol-lowering medications (statins...

Sponsor: National University of SingaporeEnrolling: 4502 locations
RECRUITINGPhase 2NCT06564584

Phase 2a Study of Safety, Tolerability, and Efficacy of TLC-2716 in Subjects With Hypertriglyceridemia and NAFLD

This is a Phase 2a, randomized, double-blind, placebo-controlled study evaluating the safety, tolerability, and efficacy of 2 dose levels of TLC-2716 in subjects with...

Sponsor: OrsoBio, IncEnrolling: 304 locations
RECRUITINGNCT05693701

Multicomponent Intervention Study- Blood Donors With High Cholesterol

The purpose and objective of this study is to improve cholesterol treatment among blood donors with FH (Familial Hypercholesterolemia).

Sponsor: University of Texas Southwestern Medical CenterEnrolling: 1001 location
RECRUITINGNCT06331195

An Adapted Brazilian Cardioprotective Diet, Phytosterols and Krill Oil in Familial Hypercholesterolemia (DICA-FH)

The main objective of this randomized clinical trial is to evaluate the effects of the adapted Brazilian Cardioprotective Diet (DICA Br) supplemented or not with phytosterols...

Sponsor: Hospital do CoracaoEnrolling: 30020 locations
RECRUITINGPhase 1 / Phase 2NCT07172646

A Study of SRSD216 in Patients With Elevated Lipoprotein (a)

This is a two-part study, intended to investigate the safety, tolerability, characteristics of PK and PD of single SC dose of SRSD216 and to identify a dose range for further...

Sponsor: Sirius Therapeutics Co., Ltd.Enrolling: 841 location
RECRUITINGNCT06894251

Effect of LIMICOL®-NG on Plasma LDL-cholesterol Concentration in Subjects with Moderate Hypercholesterolemia

The goal of this clinical trial is to observe a decrease in plasma LDL cholesterol concentration of 10% (or 0.20g/L) in subjects with untreated moderate hypercholesterolemia after...

Sponsor: Institut Pasteur de LilleEnrolling: 351 location
RECRUITINGPhase 2 / Phase 3NCT06220266

Effects of Phytoestrogen From Pueraria Mirifica in Improvement of Serum Lipid Parameters in Postmenopausal Women

The goal of this clinical trial is to learn about the effects of phytoestrogen from Pueraria Mirifica in improvement of serum lipid parameters. The primary question it aims to...

Sponsor: Dhurakij Pundit UniversityEnrolling: 101 location
RECRUITINGPhase 2NCT06488105

Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial

Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders (EMERALD) is a protocolized intervention based on American College of Cardiology/American Heart Association...

Sponsor: Wake Forest University Health SciencesEnrolling: 1301 location
RECRUITINGNCT05988866

Effects of a Digital Health Application (Lipodia) on LDL-cholesterol Levels

The goal of this clinical trial is to find out if lipodia, a digital health intervention, can help lower cholesterol levels and improve other health measures in adults with high...

Sponsor: Gaia AGEnrolling: 2721 location
RECRUITINGNCT05430828

Evaluation of Adherence, Persistence and Efficacy of Treatment With PCSK9 Inhibitors in Italy

Evaluation of adherence, persistence and efficacy of treatment with PCSK9 inhibitors in a real-life Italian population.

Sponsor: Federico II UniversityEnrolling: 500020 locations
RECRUITINGNCT06966258

Inspire HER: Inspiring the Heart and Emotions for Radical Health

Poor heart health puts Black women at risk for a shorter life with more illness than people of any other non-indigenous racial group. We will refine and conduct a randomized,...

Sponsor: University of Alabama at BirminghamEnrolling: 901 location
RECRUITINGNCT05962372

Culturally Adapted Dietary Clinical Trial in PR

This project will determine whether a diet culturally adapted to adults in Puerto Rico can effectively decrease cardiometabolic risk factors. This will help define a...

Sponsor: Harvard School of Public Health (HSPH)Enrolling: 2501 location
RECRUITINGNCT04485871

Targeting Risk Factors for Diabetes in Subjects With Normal Blood Cholesterol Using Omega-3 Fatty Acids

Every 3 minutes a new case of diabetes is diagnosed in Canada, mostly type 2 diabetes (T2D) increasing the risk for heart disease. T2D and heart disease share many common risk...

Sponsor: Institut de Recherches Cliniques de MontrealEnrolling: 481 location
RECRUITINGPhase 4NCT06789432

Efficacy and Safety of Atorvastatin and Ezetimibe (10/10mg) Fixed Dose Combination Versus Atorvastatin (20mg)...

The goal of this clinical trial is to evaluate the efficacy and safety of a fixed-dose combination of atorvastatin (10 mg) and ezetimibe (10 mg) compared to atorvastatin (20 mg)...

Sponsor: Dr. Md. Alimur RezaEnrolling: 5001 location
RECRUITINGNCT06055036

Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention

Lower attainment of cardiovascular health (CVH), indicated by the American Heart Association's Life's Simple 7 (LS7; physical activity, diet, cholesterol, blood pressure, body...

Sponsor: Ohio State UniversityEnrolling: 3401 location
RECRUITINGNCT07119658

Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial

The objective of this study is to pilot a multifaceted, optimized intervention for metabolic syndrome (MetS) in emergency department patients to establish feasibility....

Sponsor: Indiana UniversityEnrolling: 201 location
RECRUITINGNCT06049420

Lifestyle Medicine: Establishing Clinical Approaches to Chronic Disease for Rural Patients

Developed nations worldwide are currently enduring a health crisis, as chronic diseases continue to decrease quality of life and promote additional disease states or even death...

Sponsor: West Virginia School of Osteopathic MedicineEnrolling: 951 location
RECRUITINGNCT07004777

Effect of Consuming n-3 PUFAs Rich Foods on Triglyceride Concentration and Lipoprotein Composition

Hypertriglyceridemia is one of the most prevalent lipid profile disorders and is linked to a large proportion of mortality in Mexico and around the world. Various international...

Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranEnrolling: 3751 location
RECRUITINGNCT05614219

Familial Hypercholesterolemia Interpretive Comment - Nudging to Detection.

Familial hypercholesterolemia is the most common inherited disease of the lipid metabolism, however it remains underdiagnosed. Only 15 % of 30.000 possible patients have been...

Sponsor: Odense University HospitalEnrolling: 20002 locations
RECRUITINGPhase 3NCT07102628

Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute...

The purpose of this trial is to learn about the effects of inclisiran in people with serious heart conditions (acute coronary syndromes), when this treatment is started early...

Sponsor: Novartis PharmaceuticalsEnrolling: 30020 locations
RECRUITINGPhase 3NCT06597006

Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial...

This is a pivotal phase III study designed to evaluate safety, tolerability, and efficacy of inclisiran in children (aged 2 to \<12 years) with homozygous familial...

Sponsor: Novartis PharmaceuticalsEnrolling: 918 locations
RECRUITINGNCT06684106

Ursodeoxycholic Acid Attenuates Statin-Induced Impaired Glucose Tolerance

The purpose of this clinical trial is to understand whether the drug Ursodeoxycholic acid (UDCA) can prevent glucose intolerance in participants with hyperlipidemia who are taking...

Sponsor: First Affiliated Hospital Xi'an Jiaotong UniversityEnrolling: 1282 locations
RECRUITINGNCT06065098

Church-based Health Intervention to Eliminate Racial Inequalities in Cardiovascular Health

Cardiovascular disease (CVD) is the leading cause of death in the US general population. Although CVD mortality rates declined for both Black and White populations during the past...

Sponsor: Tulane UniversityEnrolling: 8061 location
RECRUITINGNCT06743659

Computerized Decision Support for Identification and Management of Familial Hypercholesterolemia

The goal of this clinical trial is to learn if a computer alert can aid clinicians in identifying patients with a genetic type of high cholesterol, called Familial...

Sponsor: Brigham and Women's HospitalEnrolling: 4501 location
RECRUITINGNCT06703151

To Understand the Self-care Ability of Farmers and Fishermen With CMDs (Hypertension, Heart Disease, Hyperlipidemia,...

This project will be based on nursing scholar Dorothea Orem's self-care theory, integrating the concept of the \[life essential 8, LE8\] proposed by the American Heart...

Sponsor: Chang Gung Memorial HospitalEnrolling: 3381 location
RECRUITINGPhase 3NCT06880770

Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis

This study will evaluate the efficacy and safety of plozasiran in approximately 288 adult participants with severe hypertriglyceridemia (SHTG) and history of at least two prior...

Sponsor: Arrowhead PharmaceuticalsEnrolling: 28820 locations
RECRUITINGPhase 2NCT06822946

Zhibitai Capsules for the Treatment of Primary Hyperlipidemia

Exploring the benefit risk ratio of increase in dosage of Zhibitai capsules (2 capsules at a time, 2 times a day) compared to the original dosage (1 capsule at a time, 1 day)

Sponsor: Chengdu Diao Jiuhong Pharmaceutical FactoryEnrolling: 1921 location
RECRUITINGNCT06439654

Atlantic Lipid Lowering Treatment Optimization Program

Hypercholesterolemia is recognized as the major driver for cardiovascular morbidity and mortality. To help address this in our community, Atlantic Medical Group (AMG) formed a...

Sponsor: Atlantic Health SystemEnrolling: 2502 locations

Showing 50 of 100 trials.Search all Hyperlipidemia trials